Hellwig S, Robin F, Drossard J, Raven N P, Vaquero-Martin C, Shively J E, Fischer R
Institut für Biologie I (Botanik/Molekulargenetik), RWTH Aachen, D-52074 Aachen, Germany.
Biotechnol Appl Biochem. 1999 Dec;30(3):267-75.
Carcinoembryonic antigen (CEA) is a 180-kDa glycoprotein found on the surface of normal colon and malignant human adenocarcinomas. Recently, a fusion protein containing two of the seven Ig-like domains present in CEA (N and A3) has been constructed and expressed in Pichia pastoris [You, Hefta, Yazaki, Wu and Shively (1998) Anticancer Res. 18, 3193-3201]. Here, we report the generation and selection of a multi-copy clone expressing this fusion protein, the optimization of the shake-flask expression protocol and the upscaled production of CEA N-A3 using fermentation technology. P. pastoris transformants secreting the CEA N-A3 domain were generated by electrotransformation of the GS115 host strain with the pPIC9K vector containing the CEA N-A3 cDNA [You, Hefta, Yazaki, Wu and Shively (1998) Anticancer Res. 18, 3193-3201] then screened for CEA N-A3 expression and G418 resistance. The recombinant CEA N-A3 domain was detected in the culture supernatant using the monoclonal anti-CEA antibody T84.66. Optimization of methanol-induction conditions resulted in a high-methanol shake-flask expression protocol yielding significantly increased CEA N-A3 levels. Fermentation and culture conditions were optimized for 5-l working-volume fermentations and CEA N-A3 was affinity purified using Ni-IDA (imino di-acetic acid) affinity chromatography from the clarified fermentation supernatant. Peptide N-glycosidase F treatment revealed that the recombinant protein was heavily glycosylated but expressed as a single polypeptide of 28 kDa with no evidence of proteolytic degradation. Our results demonstrate that functional CEA N-A3 domain can be produced in sufficient quantities in P. pastoris for structural analysis or diagnostic applications. To our knowledge, this article represents the first report on the production of a human tumour antigen through fermentation.
癌胚抗原(CEA)是一种180 kDa的糖蛋白,存在于正常结肠和人类恶性腺癌表面。最近,一种包含CEA中七个免疫球蛋白样结构域中的两个(N和A3)的融合蛋白已被构建并在毕赤酵母中表达[You、Hefta、Yazaki、Wu和Shively(1998年)《抗癌研究》18卷,3193 - 3201页]。在此,我们报告了表达该融合蛋白的多拷贝克隆的产生与筛选、摇瓶表达方案的优化以及利用发酵技术大规模生产CEA N - A3。通过用含有CEA N - A3 cDNA的pPIC9K载体对GS115宿主菌株进行电转化,产生分泌CEA N - A3结构域的毕赤酵母转化子[You、Hefta、Yazaki、Wu和Shively(1998年)《抗癌研究》18卷,3193 - 3201页],然后筛选CEA N - A3表达和G418抗性。使用单克隆抗CEA抗体T84.66在培养上清液中检测重组CEA N - A3结构域。甲醇诱导条件的优化产生了一种高甲醇摇瓶表达方案,使CEA N - A3水平显著提高。针对5升工作体积发酵优化了发酵和培养条件,并使用镍 - 亚氨基二乙酸(Ni - IDA)亲和色谱从澄清的发酵上清液中亲和纯化CEA N - A3。肽N - 糖苷酶F处理表明重组蛋白高度糖基化,但以28 kDa的单一多肽形式表达,没有蛋白水解降解的迹象。我们的结果表明,功能性CEA N - A3结构域可以在毕赤酵母中大量生产,用于结构分析或诊断应用。据我们所知,本文是关于通过发酵生产人类肿瘤抗原的首次报道。